OTC 인공눈물 시장 규모, 점유율, 성장 분석 : 제품 유형별, 성분 유형별, 용기 유형별, 제제별, 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global OTC Artificial Tears Market size was valued at USD 5.5 Billion in 2024 and is poised to grow from USD 5.78 Billion in 2025 to USD 8.53 Billion by 2033, growing at a CAGR of 5.0% during the forecast period (2026-2033).

The global OTC artificial tears market is experiencing significant growth, primarily driven by the rising prevalence of dry eye disease associated with aging populations and increased screen time. This market encompasses a variety of over-the-counter lubricants, gels, and ointments designed to alleviate discomfort from tear film instability. The evolution from basic saline drops to advanced, preservative-free solutions highlights manufacturer innovation, particularly among leading brands. Enhanced consumer access via e-commerce and pharmacy networks facilitates quicker product adoption, while rising online demand prompts manufacturers to boost production of targeted, lipid-based therapies. This dynamic fosters competition and attracts private label entrants, amplifying product accessibility. Furthermore, consumers utilizing telemedicine services enhance retail strategies, creating a symbiotic relationship between prescription and non-prescription segments that propels market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global OTC Artificial Tears market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global OTC Artificial Tears Market Segments Analysis

The global OTC artificial tears market is segmented based on product type, ingredient type, container type, formulation, application, distribution channel, and region. By product type, the market includes ointments, emulsions, gels, spray solutions, and suspensions. Based on ingredient type, it is categorized into cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, and polyethylene glycol. By container type, the market is divided into plastic single-dose, plastic multi-dose, and others. In terms of formulation, it is segmented into preservative-based and non-preservative-based products. Based on application, the market covers allergies, infections, UV and blue light protection, contact lens moisture, and others. By distribution channel, it includes drug stores and retail pharmacies, as well as hospital pharmacies. Regionally, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global OTC Artificial Tears Market

A significant market driver for the Global OTC Artificial Tears Market is the rising prevalence of eye-related issues, particularly dry eye syndrome, attributed to factors such as increased screen time, environmental pollutants, and aging populations. As more individuals experience discomfort from digital eye strain and dry eyes, the demand for accessible and effective over-the-counter artificial tear solutions continues to grow. Additionally, heightened awareness of eye health and the importance of lubricating eye drops for everyday comfort further propels market expansion. The convenience of OTC products, combined with extensive marketing efforts, fosters consumer confidence in self-managing their eye care needs.

Restraints in the Global OTC Artificial Tears Market

One key market restraint for the global OTC artificial tears market is the increasing competition from prescription alternatives that offer enhanced efficacy for dry eye treatment. These prescription options can provide stronger relief and tailored formulations that address specific underlying conditions, making them more appealing to consumers seeking long-term solutions. Additionally, the potential for side effects or ineffective relief from over-the-counter products may discourage users from relying on artificial tears, prompting them to opt for prescription treatments instead. This shift could negatively impact the growth potential of the OTC artificial tears segment, limiting its market share and limiting product adoption.

Market Trends of the Global OTC Artificial Tears Market

The Global OTC Artificial Tears market is experiencing a significant shift towards personalized ocular care solutions, as consumers and clinicians favor customized treatments over generic options. This trend is fueled by advancements in diagnostic capabilities and telemedicine, enabling tailored eye drop formulations that align with individual tear film characteristics and lifestyle needs. Enhanced personalization not only improves treatment adherence and efficacy but also fosters collaboration between specialty clinics and manufacturers to develop unique, evidence-based products. This evolving landscape is poised to generate sustained brand loyalty and trust among patients, ultimately driving growth and innovation within the artificial tears market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global OTC Artificial Tears Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ointments
• Emulsions
• Gels
• Spray Solutions
• Suspensions

Global OTC Artificial Tears Market Size by Ingredient Type & CAGR (2026-2033)

• Market Overview
• Cellulose Derived Tears
• Glycerin Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol

Global OTC Artificial Tears Market Size by Container Type & CAGR (2026-2033)

• Market Overview
• Plastic Single-Dose
• Plastic Multi-Dose
• Others

Global OTC Artificial Tears Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Preservative Based
• Non-Preservative Based

Global OTC Artificial Tears Market Size by Applications & CAGR (2026-2033)

• Market Overview
• Allergies
• Infections
• UV/Blue Light Protection
• Contact Lens Moisture
• Others

Global OTC Artificial Tears Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Drug Stores/Retail Pharmacies
• Hospital Pharmacies

Global OTC Artificial Tears Market Size & CAGR (2026-2033)

• North America (Product Type, Ingredient Type, Container Type, Formulation, Applications, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Ingredient Type, Container Type, Formulation, Applications, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Ingredient Type, Container Type, Formulation, Applications, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Ingredient Type, Container Type, Formulation, Applications, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Ingredient Type, Container Type, Formulation, Applications, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• SANTEN PHARMACEUTICAL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAUSCH & LOMB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALLERGAN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABBOTT LABORATORIES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JOHNSON & JOHNSON
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LUMECARE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIMILASAN CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URSAPHARM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOVARTIS AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCUSOFT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THERAPEUTICS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isotine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HARTMANN GROUP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYAFFLOW
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENTACLE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COLLIER PHARMACEUTICALS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OYSTER POINT PHARMA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INNOVATIVE PHARMACEUTICALS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EYEONAY
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HILTON PHARMA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations